Use of EPA and DHA in secondary prevention

Details for Australian Patent Application No. 2003229993 (hide)

Owner Pronova BioPharma Norge AS

Inventors Shearman, Cliff; Calder, Philip; Grimble, Robert; Gallagher, Patrick

Agent Watermark

Pub. Number AU-B-2003229993

PCT Number PCT/GB03/01945

PCT Pub. Number WO2003/092673

Priority 0210212.7 03.05.02 GB; 0307625.4 02.04.03 GB

Filing date 2 May 2003

Wipo publication date 17 November 2003

Acceptance publication date 24 July 2008

International Classifications

A61K 31/202 (2006.01)

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/232 (2006.01)

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 0210212.7 03.05.02 GB; 0307625.4 02.04.03 GB

8 January 2004 Application Open to Public Inspection

  Published as AU-B-2003229993

22 May 2008 Alteration of Name

  The name of the applicant has been altered to Pronova BioPharma Norge AS

24 July 2008 Application Accepted

  Published as AU-B-2003229993

20 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003229994-Injection device

2003229992-Dehumidifying device